Q3 2018 13F Holders as of 30 Sep 2018
-
Type / Class
-
Equity / COMMON STOCK
-
Total 13F shares
-
40,126,806
-
Share change
-
-295,137
-
Total reported value
-
$1,845,781,241
-
Put/Call ratio
-
93%
-
Price per share
-
$46.02
-
Number of holders
-
157
-
Value change
-
-$8,485,354
-
Number of buys
-
71
-
Number of sells
-
79
Institutional Holders of ARENA PHARMECEUTICALS INC - COMMON STOCK (ARNA) as of Q3 2018
As of 30 Sep 2018,
ARENA PHARMECEUTICALS INC - COMMON STOCK (ARNA) was held by
157 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
40,126,806 shares.
The largest 10 holders included
WELLINGTON MANAGEMENT GROUP LLP, BlackRock Inc., Vanguard Group Inc, FMR LLC, Partner Fund Management, L.P., STATE STREET CORP, PERCEPTIVE ADVISORS LLC, Alyeska Investment Group, L.P., PRIMECAP MANAGEMENT CO/CA/, and Point72 Asset Management, L.P..
This page lists
157
institutional shareholders reporting positions in this security
for the Q3 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.